Syensqo
A global science company developing advanced materials and specialty chemicals that enhance quality of life through innovative solutions across aerospace, automotive, electronics, healthcare, and consumer markets.
- CEO / Founder
- Mike Radossich
- Team Size
- 13,000+
- Stage
- Active
- Total Funding
- Undisclosed
- Latest Round
- IPO
- Key Investors
- BlackRock (4.17% stake), Institutional Investors, Public Market Investors
Technology & Products
Key Products
["Specialty Polymers (PEEK, polysulfones, fluoroelastomers, fluorinated fluids) for aerospace, electronics, and healthcare","Composite Materials (thermoset/thermoplastic composites, prepregs, ReGen bio-based resins) for aerospace and automotive","Novecare (surfactants, natural ingredients, formulations) for personal care, agriculture, and mining","Battery Materials and Green Hydrogen solutions for clean energy applications","Renewable Materials and Biotechnology-enabled ingredients for sustainable products","Aroma Performance and Technology Solutions for food, flavors, and industrial applications"]
Technological Advantage
Integrated innovation ecosystem spanning specialty polymers, composite materials, fluorochemistry, and biosolutions; strong R&D capabilities with 2,000+ scientists and engineers; active IP portfolio management protecting proprietary technologies; focus on sustainable solutions through renewable materials, circular chemistry, and biotechnology acquisitions.
Differentiation
Value Proposition
Provides the industry's broadest portfolio of specialty polymers and advanced materials enabling customers to develop safer, cleaner, and more sustainable products with superior performance in extreme environments, while transitioning to renewable and circular solutions.
How They Differentiate
Industry's broadest specialty polymer portfolio with 50+ years of materials science heritage; leverages AI-driven research through SyGPT for accelerated material discovery; integrated innovation ecosystem spanning specialty polymers, composite materials, fluorochemistry, and biosolutions with strong focus on sustainable and circular technologies
Market & Competition
Target Customers
Original equipment manufacturers (OEMs) and industrial companies across aerospace, automotive, electronics, healthcare, consumer goods, agriculture, and energy sectors seeking high-performance materials and specialty chemicals
Industry Verticals
["Aerospace & Defense","Automotive & Transportation","Electronics & Semiconductors","Healthcare & Medical Devices","Consumer Goods & Packaging","Agriculture & Food","Energy & Clean Technology","Industrial Manufacturing"]
Competitors
Victrex Plc; Evonik Industries AG; Arkema
Growth & Milestones
Growth Metrics
€6.85B revenue (2024); 21.5% EBITDA margin; 82% cash conversion; €390M free cash flow to shareholders (2024); 13,000+ employees across 30 countries
Major Milestones
["Successfully completed spin-off from Solvay SA on December 11, 2023","Trading began on Euronext Brussels and Paris with €9.5B market capitalization","Joined BEL20 index shortly after public listing","2024 first full year as independent company achieving €6.85B revenue","Announced €300M share buyback program in Q4 2024","Mike Radossich assumed CEO role in January 2026","Launched SyGPT AI chatbot in partnership with Microsoft Azure","Partnered in Climate Impulse project for green hydrogen aircraft (2024)"]
Notable Customers
Microsoft; Vertical Aerospace; OCP Group; Sinopec; BASF; SABIC; Automotive OEMs; Aerospace manufacturers